Globus Medical A Stock Total Debt
GM0N Stock | EUR 78.00 2.00 2.50% |
GLOBUS MEDICAL A fundamentals help investors to digest information that contributes to GLOBUS MEDICAL's financial success or failures. It also enables traders to predict the movement of GLOBUS Stock. The fundamental analysis module provides a way to measure GLOBUS MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GLOBUS MEDICAL stock.
GLOBUS |
GLOBUS MEDICAL A Company Total Debt Analysis
GLOBUS MEDICAL's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Based on the latest financial disclosure, GLOBUS MEDICAL A has a Total Debt of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
GLOBUS Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GLOBUS MEDICAL's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GLOBUS MEDICAL could also be used in its relative valuation, which is a method of valuing GLOBUS MEDICAL by comparing valuation metrics of similar companies.GLOBUS MEDICAL is currently under evaluation in total debt category among its peers.
GLOBUS Fundamentals
Current Valuation | 6.66 B | |||
Price To Book | 4.15 X | |||
Price To Sales | 7.57 X | |||
Revenue | 1.02 B | |||
EBITDA | 304.5 M | |||
Net Income | 190.17 M | |||
Cash Flow From Operations | 178.47 M | |||
Price To Earnings To Growth | 2.80 X | |||
Number Of Employees | 12 | |||
Market Capitalization | 6.1 B | |||
Total Asset | 2.08 B | |||
Net Asset | 2.08 B |
About GLOBUS MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GLOBUS MEDICAL A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GLOBUS MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GLOBUS MEDICAL A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.